Andy de Deene

Corporate Officer/Principal at OXURION NV

Consumer Services

Health Technology

Profile

Dr. Andy de Deene is a Chief Development Officer at Oxurion NV.
Dr. de Deene was previously employed as a Director & Manager by The Janssen Research Foundation and a Director & Manager by Xcellentis NV.
He received his graduate degree from Universität zu Köln, a graduate degree from Ghent University, an MBA from Vlerick Leuven Gent Management School and a doctorate degree from Ghent University.

Andy de Deene active positions

Companies	Position	Start
OXURION NV	Corporate Officer/Principal	01/06/2008

All active positions of Andy de Deene

Former positions of Andy de Deene

Companies	Position	End
Xcellentis NV Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds	Director/Board Member	-
The Janssen Research Foundation	Director/Board Member	-

See the detail of Andy de Deene's experience

Training of Andy de Deene

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andy de Deene's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Universität zu Köln Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vlerick Leuven Gent Management School Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxurion NV Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer	Health Technology
Xcellentis NV Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds	Health Technology
The Janssen Research Foundation